Navigation Links
Roche Holds Sixth Annual Children's Walk in Nutley
Date:11/21/2008

- More than 800 Employees Volunteer to Support Children Affected by HIV/AIDS in New Jersey and Africa -

NUTLEY, N.J., Nov. 21 /PRNewswire/ -- Today, more than 800 local Roche employees are participating in the Sixth Annual Roche Children's Walk to raise funds to support children infected and affected by HIV/AIDS in New Jersey and Africa. Employees who volunteer for the 5K Walk, which takes them through the township of Nutley, collect donations for their efforts, and Roche matches these funds.

In addition to Nutley, the Roche Children's Walk takes place at 101 company locations worldwide, including operations in Branchburg, New Jersey; Indianapolis, Indiana; Florence, South Carolina; Boulder, Colorado; Palo Alto and Pleasanton, California; as well as in Basel, Switzerland. To date, Roche has raised approximately five million Swiss francs since the first AIDS walk in 2003. In 2007, more than 14,000 employees took part around the globe.

A portion of donations from the Roche Children's Walk in Nutley are distributed to community-based non-profit organizations serving people living with HIV/AIDS through the New Jersey AIDS Partnership (NJAP). Since the Walk's inception in 2003, Roche has donated over $350,000 to NJAP. According to the New Jersey Department of Health and Senior Services, 34,470 people were reported living with HIV/AIDS in New Jersey in 2007. For information on NJAP, please access http://www.hyacinth.org/hyacinth/news/NewJerseyAIDSPartnership.jsp.

"We are very fortunate to have a supporter like Roche," said Paula Toynton, director of the New Jersey AIDS Partnership. "The generosity of their employees is amazing, and we are so grateful for their continued support and enthusiasm, which enables us to provide needed services throughout the
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness
2. Rochester Medical Reports Record Fourth Quarter Sales and Record Annual Sales
3. Primary Insomnia Tied to Brain Neurochemical Imbalance
4. Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults
5. Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform
6. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
7. Genentech/Roche/Chugais Avastin Will Garner More Than 20 Percent of the Total Breast Cancer Drug Market in 2017
8. Balloon Manor Reappears in Rochester
9. Safety Threat to Rochester Still Remains Despite Approval Of Canadian Pacifics Railroad Acquisition Of DM&E
10. Rochester Medical Implants Achieves ISO 13485:2003 Certification for Medical Device Manufacturing
11. Autovan Donates Wheelchair-Accessible Van; Brings Greater Mobility to Facility in Rochester, New York

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)..., Nov. 9 Highlighting a commitment...th advanced entertainment and digital display tech...atest Long-Term Care and Hospital Grade LCD HDTVs ... for the Aging 2009 annual meeting and exposition ... new line of "HealthView(TM)" Long-Term Care LCD H...
(Date:11/9/2009)...K, Nov. 9 /PRNewswire/ -- Phoenix House , the...e treatment and prevention program, announced toda...lly and internationally recognized leader in subst...al Officer, effective January 1, 2010. ,, "Dr...e abuse treatment research and her work has result...
(Date:11/9/2009)...ents Support Experimental Procedure for Preteen So...swire/ -- For parents of children with cancer, the...e steadily improved for decades. Among the bad new...nfertility. ,, Boys diagnosed with cancer who...y to preserve their fertility: before undergoing c...
(Date:11/9/2009)...ildren,s Research Hospital and the University of F...aboration to provide proton therapy for St. Jude p...the first clinical study to evaluate the use of pr...unger than 3 years old. , Under the clinical p...roton therapy at the UF Proton Therapy Institute i...
(Date:11/9/2009)...10 million people around the world suffer from cat...Frankfurt and his coauthors discuss cataract surge...the current issue of Deutsches rzteblatt Internat...533;). , Blindness is usually due to opacificati...0 cataract operations are performed each year. Cat...
Breaking Medicine News(10 mins):Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 2Health News:Phoenix House Appoints Dr. Deni Carise as Chief Clinical Officer - Internationally Recognized Leader in Substance Abuse Treatment and Research 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2
...ce in Primary and Key Secondary Endpoints at Both,...aintenance Effects Seen in,the First Phase II Stud...FORD, England, October 16 /PRNewswire-FirstCall/,-...omnia patients with daytime sleepiness. These top-...
...16 Many routine surgical biopsies,could become a ...aring,reviewing and diagnosing noninvasive digital...d Inc.,s VivaNet(TM) telemedicine server and its,V...urgically biopsy many,patients. "VivaScope imaging...
...utive to Lead Growing Medical Device Firm, SANTA ...eading provider of innovative medical devices used...ons for the minimally invasive treatment of,deep v...utive Officer. Mr. Cramer joined Bacchus Vascular...
...he following is an,event announcement from the Bro...00 a.m. - 10:30 a.m., The Brookings Institution ...shington, DC, Donor assistance for health-related...ed to achieve the Millennium,Development Goals. Ad...
... Wyeth (NYSE: WYE ),confirmed today that it will...rrester v. Wyeth cases in the Second Judicial Dist...al motions to The Honorable Robert H. Perry,who pr...General Counsel.,"The events of last week and the ...
... 15 HealthSouth,Corporation (NYSE: HLS ) today a...at 8:30 a.m. Eastern Time on Tuesday, November 6, ... of 2007. The conference call may be accessed by ...mately 10 minutes before the,start of the call to ...
Other Medicine News:Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 2Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 3Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 4Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 5Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 6Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 7Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 8Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 9Health News:Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness 10Health News:VivaScope(R) Confocal Imager May Eliminate Need for Routine Skin Biopsies for Dermatology Patients 2Health News:Bacchus Vascular Names Scott Cramer as President and CEO 2Health News:Brookings: Donor Perspectives on Innovative Financing for Global Health 2Health News:Wyeth to Appeal Nevada Hormone Therapy Trial Verdict 2Health News:Wyeth to Appeal Nevada Hormone Therapy Trial Verdict 3Health News:HealthSouth Announces Date of Third Quarter Earnings Conference Call 2
(Date:11/9/2009)...wire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT )...athologists, oncologists and the pharmaceutical in...ke presentations at two upcoming investor conferen... will be made at the Lazard Capital Markets Sixth ...sday, November 17. The conference will be held at ...
(Date:11/7/2009)...re/ -- Most patients with hereditary angioedema (H...g HAE attack giving the patients sufficient time t...sociated with that attack, according to survey fin... of Allergy, Asthma & Immunology (ACAAI) Annua...atigue and nausea, which occur frequently before a...
(Date:11/6/2009).... 6 In consultation with the U.S. ...r Healthcare, Division of McNEIL-PPC, Inc., is ini...product lots of TYLENOL® Arthritis Pain Caple...PEN CAP. McNeil is initiating the recall after ide...ated with these lots that led to a small number of...
Breaking Medicine Technology:Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 2Prodromal Symptoms Warn of Hereditary Angioedema Attacks, Give Patients Time to Start Therapy and Decrease Morbidity 3McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2Ash Stevens Plans 246 Million Facility Expansion to Bolster CMC Capabilities 14293 1Ash Stevens Plans 246 Million Facility Expansion to Bolster CMC Capabilities 14293 2Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 1Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 2Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 3Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 4Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 5Orexigen 28R 29 Therapeutics Phase 2b Trial for Empatic 28TM 29 Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus 58518 6Have a Healthier Halloween with Tigers Milk 28R 29 58516 1Have a Healthier Halloween with Tigers Milk 28R 29 58516 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: